|Articles|September 7, 2017
- Pharmaceutical Commerce - September/October 2017
Cold Chain 2017 Directory
Advertisement
Articles in this issue
about 8 years ago
Patient data saves livesabout 8 years ago
MDM’s growing role in running healthcare businessesover 8 years ago
The power of strategic data standardizationover 8 years ago
2017 Cold Chain Outlookover 8 years ago
Is the opioid crisis a national emergency?over 8 years ago
It’s time for an industry guideline on patient support servicesover 8 years ago
A conversation with Greg Flynn, Ashfield Healthcare USover 8 years ago
LogiPharma meeting highlights digital transformationover 8 years ago
Drug development in rare diseasesNewsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
2
Cencora Accelerates Global 3PL Expansion With Major Investments in Cold Chain and Specialty Logistics
3
What MFN Pricing Means for Future Drug Development
4
Pharma Pulse: Pazdur Retires from FDA, While Public Trusts AMA Over CDC on Vaccines, and New Data Redefines Adherence as an Emotional Crisis
5
